Trial Profile
An Open-label Feasibility Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome: A Pilot Study.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Fibromyalgia
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 31 Oct 2019 Planned End Date changed from 1 May 2014 to 1 Aug 2010.
- 31 Oct 2019 Planned primary completion date changed from 1 May 2014 to 1 Aug 2010.
- 31 Oct 2019 Status changed from discontinued to withdrawn prior to enrolment.